Fly News Breaks for September 5, 2019
Sep 5, 2019 | 13:33 EDT
Wedbush analyst Liana Moussatos raised her price target for Global Blood Therapeutics to $120 from $103 after the FDA accepted for filing the company's New Drug Application seeking accelerated approval for voxelotor and indicated that it is not currently planning to hold an advisory committee meeting to discuss the application. Moussatos keeps an Outperform rating on the shares.
News For GBT From the Last 2 Days
There are no results for your query GBT